Article
Current Developments of Clinical Sequencing and the Clinical Utility of Polygenic Risk Scores in Inflammatory Diseases.
Frontiers in immunology - 1 Jan 2020
Hübenthal Matthias, Löscher Britt-Sabina, Erdmann Jeanette, Franke Andre, Gola Damian, König Inke R, Emmert Hila
Abstract excerpt
In this mini-review, we highlight selected research by the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Precision Medicine in Chronic Inflammation" focusing on clinical sequencing and the clinical utility of polygenic risk scores as well as its implication on precision medicine in the field of the inflammatory diseases inflammatory bowel disease, atopic dermatitis and coronary artery disease....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
